These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2937482)
1. Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Ohlsson A; Lindgren JE; Andersson S; Agurell S; Gillespie H; Hollister LE Biomed Environ Mass Spectrom; 1986 Feb; 13(2):77-83. PubMed ID: 2937482 [TBL] [Abstract][Full Text] [Related]
2. Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking. Johansson E; Ohlsson A; Lindgren JE; Agurell S; Gillespie H; Hollister LE Biomed Environ Mass Spectrom; 1987 Sep; 14(9):495-9. PubMed ID: 2960395 [TBL] [Abstract][Full Text] [Related]
3. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407 [TBL] [Abstract][Full Text] [Related]
4. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Meresaar U; Nilsson MI; Holmstrand J; Anggård E Eur J Clin Pharmacol; 1981; 20(6):473-8. PubMed ID: 7286059 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cannabidiol in dogs. Samara E; Bialer M; Mechoulam R Drug Metab Dispos; 1988; 16(3):469-72. PubMed ID: 2900742 [TBL] [Abstract][Full Text] [Related]
6. Characterization of blood disappearance and tissue distribution of [3H]cannabidiol. Siemens AJ; Walczak D; Buckley FE Biochem Pharmacol; 1980 Feb; 29(3):462-4. PubMed ID: 7362660 [No Abstract] [Full Text] [Related]
7. Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications. Perucca E; Bialer M CNS Drugs; 2020 Aug; 34(8):795-800. PubMed ID: 32504461 [TBL] [Abstract][Full Text] [Related]
8. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain. Alozie SO; Martin BR; Harris LS; Dewey WL Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544 [TBL] [Abstract][Full Text] [Related]
10. Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans. Consroe P; Kennedy K; Schram K Pharmacol Biochem Behav; 1991 Nov; 40(3):517-22. PubMed ID: 1666917 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641 [TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans. Manini AF; Yiannoulos G; Bergamaschi MM; Hernandez S; Olmedo R; Barnes AJ; Winkel G; Sinha R; Jutras-Aswad D; Huestis MA; Hurd YL J Addict Med; 2015; 9(3):204-10. PubMed ID: 25748562 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant. Ravula A; Chandasana H; Setlow B; Febo M; Bruijnzeel AW; Derendorf H J Pharm Biomed Anal; 2018 Oct; 160():119-125. PubMed ID: 30077950 [TBL] [Abstract][Full Text] [Related]
15. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers. Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope. Guerret M; Cheymol G; Hubert M; Julien-Larose C; Lavene D Eur J Clin Pharmacol; 1989; 37(4):381-5. PubMed ID: 2598970 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration in surgical patients: simultaneous investigation of absorption and disposition kinetics using stable isotopes. Burm AG; Van Kleef JW; Vermeulen NP; Olthof G; Breimer DD; Spierdijk J Anesthesiology; 1988 Oct; 69(4):584-92. PubMed ID: 3177919 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs. Samara E; Bialer M Drug Metab Dispos; 1988; 16(6):875-9. PubMed ID: 2907468 [TBL] [Abstract][Full Text] [Related]
19. Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Agurell S; Carlsson S; Lindgren JE; Ohlsson A; Gillespie H; Hollister L Experientia; 1981 Oct; 37(10):1090-2. PubMed ID: 6273208 [No Abstract] [Full Text] [Related]
20. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Babalonis S; Haney M; Malcolm RJ; Lofwall MR; Votaw VR; Sparenborg S; Walsh SL Drug Alcohol Depend; 2017 Mar; 172():9-13. PubMed ID: 28088032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]